New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine

Voprosy Virusologii

Volumn 56, Issue 2, 2011, Pages 36-39

  Shibnev, V A ^a   Garayev, T M ^a   Flnogenova, M P ^a   Shevchenko, E S ^a   Burtseva, E I ^a  

^a N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

Author keywords

1 adamantane carboxylic acid; Adamantine derivatives; Influenza a; Resistance; Rimantadine

Indexed keywords

INFLUENZA A VIRUS;

EID: 79955575789     PISSN: 05074088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Atsushi Okada, Takashi Miura, Hideo Takeuchi. Protonation of histidine and histidine-tryptophan interaction in the activation of the M2 ion channel from influenza A virus Biochemistry. 2001. 40. 6053-6060.
2. Chittima Laohpongspaisan, Thanyada Rungrotmongkol, Pathumwadee Intharathep et al. Why amantadine loses its function in influenza M2 mutants: MD simulations J. Chem. Infect. Model. 2009. 49.P. 847-852.
3. Halonen P., Mujunen R., Mantyjarvi R. et al. On the preventive effect of amantadine hydrochloride in influenza and other respiratory viral infections Sotilaslaak Aikak.1965.Vol. 40, N 4. 130-137.
4. Rafal M. Pielaka, Jason R. Schnelle, James J. Choua. Mechanism of drug inhibition and drug resistance of influenza A M2 channel Proc. Natl. Acad. Sci. USA. 2009.Vol. 106, N 18. 7379-7384.
5. Victoria Balannik, Jun Wang, Yuki Ohigashi et al. Design and pharmacological characterization of inhibitors of amantadineresistant mutants of the M2 ion channel of influenza A virus Biochemistry. 2009. 48. 11872-11882.
6. Victoria Balannik, Vincenzo Camevale et al. Functional studies and modeling of pore-lining residue mutants of the influenza A virus M2 ion channel Biochemistry.2010.Vol. 49. P. 696-708.